The Non-Small Cell Lung Cancer Drug Development Summit is a virtual conference dedicated to all major targeted drug and immuno-oncology clinical investigations for the largest global unmet clinical need in solid tumor indications.
The Non-Small Cell Lung Cancer Drug Development Summit covers topics such as:
- Methods of targeting different and multiple EGFR mutations
- Target identification platforms and characterize dual-target interaction in T-cell engaging therapy
- The mechanisms underlying the challenges to EGFR targeting in solid tumors and patient population responses
- The use of EGFR targeting with small molecules to cross the blood brain barrier
